Anti-biofilm peptides as a new weapon in antimicrobial warfare

Current Opinion in Microbiology

Volumn 33, Issue , 2016, Pages 35-40

  Pletzer, Daniel ^a   Coleman, Shannon R ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PEPTIDE DERIVATIVE; ANTIMICROBIAL CATIONIC PEPTIDE; BIS(3',5')-CYCLIC DIGUANYLIC ACID; CYCLIC GMP;

ANTIMICROBIAL ACTIVITY; BIOFILM; GRAM NEGATIVE BACTERIUM; INFECTION; INFECTION CONTROL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; BACTERIAL INFECTION; DRUG EFFECTS; DRUG POTENTIATION; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; PROSTHESES AND ORTHOSES; QUORUM SENSING; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; BIOFILMS; CYCLIC GMP; DRUG SYNERGISM; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; QUORUM SENSING; STAPHYLOCOCCUS AUREUS;

EID: 84974604292     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2016.05.016     Document Type: Review

References (32)

1. Jefferson K.K. What drives bacteria to produce a biofilm?. FEMS Microbiol Lett 2004, 236:163-173.
2. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
3. Neethirajan S., Clond M.A., Vogt A. Medical biofilms-nanotechnology approaches. J Biomed Nanotechnol 2014, 10:2806-2827.
4. Wu H., Moser C., Wang H.Z., Hoiby N., Song Z.J. Strategies for combating bacterial biofilm infections. Int J Oral Sci 2015, 7:1-7.
5. Taylor P.K., Yeung A.T., Hancock R.E.W. Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies. J Biotechnol 2014, 191:121-130.
6. Hancock R.E.W., Haney E.F., Gill E.E. The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol 2016, advance online publication.
7. Mansour S.C., Pena O.M., Hancock R.E.W. Host defense peptides: front-line immunomodulators. Trends Immunol 2014, 35:443-450.
8. Overhage J., Campisano A., Bains M., Torfs E.C., Rehm B.H., Hancock R.E.W. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008, 76:4176-4182.
9. Aka S.T. Killing efficacy and anti-biofilm activity of synthetic human cationic antimicrobial peptide cathelicidin hCAP-18/LL37 against urinary tract pathogens. J Microbiol Infect Dis 2015, 5:15-20.
10. de la Fuente-Nunez C., Reffuveille F., Haney E.F., Straus S.K., Hancock R.E.W. Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog 2014, 10:e1004152.
11. de la Fuente-Nunez C., Reffuveille F., Mansour S.C., Reckseidler-Zenteno S.L., Hernandez D., Brackman G., Coenye T., Hancock R.E.W. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem Biol 2015, 22:196-205.
12. Cruz J., Ortiz C., Guzman F., Fernandez-Lafuente R., Torres R. Antimicrobial peptides: promising compounds against pathogenic microorganisms. Curr Med Chem 2014, 21:2299-2321.
13. Anunthawan T., de la Fuente-Nunez C., Hancock R.E.W., Klaynongsruang S. Cationic amphipathic peptides KT2 and RT2 are taken up into bacterial cells and kill planktonic and biofilm bacteria. Biochim Biophys Acta 2015, 1848:1352-1358.
14. Batoni G., Casu M., Giuliani A., Luca V., Maisetta G., Mangoni M.L., Manzo G., Pintus M., Pirri G., Rinaldi A.C., et al. Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties. Amino Acids 2016, 48:887-900.
15. Bionda N., Fleeman R.M., de la Fuente-Nunez C., Rodriguez M.C., Reffuveille F., Shaw L.N., Pastar I., Davis S.C., Hancock R.E.W., Cudic P. Identification of novel cyclic lipopeptides from a positional scanning combinatorial library with enhanced antibacterial and antibiofilm activities. Eur J Med Chem 2016, 108:354-363.
16. De Brucker K., Delattin N., Robijns S., Steenackers H., Verstraeten N., Landuyt B., Luyten W., Schoofs L., Dovgan B., Frohlich M., et al. Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation. Antimicrob Agents Chemother 2014, 58:5395-5404.
17. Ribeiro S.M., de la Fuente-Nunez C., Baquir B., Faria-Junior C., Franco O.L., Hancock R.E.W. Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to beta-lactam antibiotics. Antimicrob Agents Chemother 2015, 59:3906-3912.
18. Tabbene O., Azaiez S., Di Grazia A., Karkouch I., Ben Slimene I., Elkahoui S., Alfeddy M.N., Casciaro B., Luca V., Limam F., et al. Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency. J Appl Microbiol 2016, 120:289-300.
19. Reffuveille F., de la Fuente-Nunez C., Mansour S., Hancock R.E.W. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother 2014, 58:5363-5371.
20. Wang Z., de la Fuente-Nunez C., Shen Y., Haapasalo M., Hancock R.E.W. Treatment of oral multispecies biofilms by an anti-biofilm peptide. PLoS One 2015, 10:e0132512.
21. Mishra N.M., Briers Y., Lamberigts C., Steenackers H., Robijns S., Landuyt B., Vanderleyden J., Schoofs L., Lavigne R., Luyten W., et al. Evaluation of the antibacterial and antibiofilm activities of novel CRAMP-vancomycin conjugates with diverse linkers. Org Biomol Chem 2015, 13:7477-7486.
22. de la Fuente-Nunez C., Korolik V., Bains M., Nguyen U., Breidenstein E.B., Horsman S., Lewenza S., Burrows L., Hancock R.E.W. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother 2012, 56:2696-2704.
23. Gao J., Tao J., Liang W., Jiang Z. Cyclic (di)nucleotides: the common language shared by microbe and host. Curr Opin Microbiol 2016, 30:79-87.
24. Romling U., Galperin M.Y., Gomelsky M. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 2013, 77:1-52.
25. Jimenez P.N., Koch G., Thompson J.A., Xavier K.B., Cool R.H., Quax W.J. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 2012, 76:46-65.
26. Romling U., Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 2012, 272:541-561.
27. Chua S.L., Sivakumar K., Rybtke M., Yuan M., Andersen J.B., Nielsen T.E., Givskov M., Tolker-Nielsen T., Cao B., Kjelleberg S., et al. C-di-GMP regulates Pseudomonas aeruginosa stress response to tellurite during both planktonic and biofilm modes of growth. Sci Rep 2015, 5:10052.
28. Maisonneuve E., Castro-Camargo M., Gerdes K. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 2013, 154:1140-1150.
29. Tamayo R. The characterization of a cyclic-di-GMP (c-Di-GMP) pathway leads to a new tool for studying c-Di-GMP metabolic genes. J Bacteriol 2013, 195:4779-4781.
30. Chua S.L., Tan S.Y., Rybtke M.T., Chen Y., Rice S.A., Kjelleberg S., Tolker-Nielsen T., Yang L., Givskov M. Bis-(3'-5')-cyclic dimeric GMP regulates antimicrobial peptide resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2013, 57:2066-2075.
31. Mishra B., Golla R.M., Lau K., Lushnikova T., Wang G. Anti-Staphylococcal biofilm effects of human cathelicidin peptides. ACS Med Chem Lett 2016, 7:117-121.
32. Pletzer D., Hancock R.E.W. Anti-biofilm peptides: potential as broad-spectrum agents. J Bacteriol 2016, PMID: 27068589.